Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roberta E Ledda"'
Autor:
Federica Sabia, Maurizio Balbi, Roberta E Ledda, Gianluca Milanese, Margherita Ruggirello, Camilla Valsecchi, Alfonso Marchianò, Nicola Sverzellati, Ugo Pastorino
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0285593 (2023)
Coronary artery calcium (CAC) is a known risk factor for cardiovascular (CV) events and mortality but is not yet routinely evaluated in low-dose computed tomography (LDCT)-based lung cancer screening (LCS). The present analysis explored the capacity
Externí odkaz:
https://doaj.org/article/37fdc2e485724e6aa8005606402b6915
Autor:
Federica Sabia, Maurizio Balbi, Roberta E. Ledda, Gianluca Milanese, Margherita Ruggirello, Camilla Valsecchi, Alfonso Marchianò, Nicola Sverzellati, Ugo Pastorino
Coronary artery calcium (CAC) is a known risk factor for cardiovascular events, but not yet routinely evaluated in Low Dose Computed Tomography (LDCT) screening. The present analysis compared the accuracy of a new automated CAC quantification versus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d71d5d7424e3fe21065307e75cf82d93
https://doi.org/10.1101/2022.06.13.22276338
https://doi.org/10.1101/2022.06.13.22276338
Autor:
Ugo Pastorino, Vito Ladisa, Sara Trussardo, Federica Sabia, Luigi Rolli, Camilla Valsecchi, Roberta E. Ledda, Gianluca Milanese, Paola Suatoni, Mattia Boeri, Gabriella Sozzi, Alfonso Marchianò, Elena Munarini, Roberto Boffi, Silvano Gallus, Giovanni Apolone
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
Cytisine, a partial agonist-binding nicotine acetylcholine receptor, is a promising cessation intervention. We conducted a single-center, randomized, controlled trial (RCT) in Italy to assess the efficacy and tolerability of cytisine as a smoking ces
Autor:
Mario Silva, Gianluca Milanese, Roberta E Ledda, Sundeep M Nayak, Ugo Pastorino, Nicola Sverzellati
Publikováno v:
The British Journal of Radiology. 95
Lung cancer screening (LCS) by low-dose computed tomography is a strategy for secondary prevention of lung cancer. In the last two decades, LCS trials showed several options to practice secondary prevention in association with primary prevention, how
Autor:
Mattia Boeri, Federica Sabia, Roberta E. Ledda, Maurizio Balbi, Paola Suatoni, Miriam Segale, Anna Zanghì, Anna Cantarutti, Luigi Rolli, Camilla Valsecchi, Giovanni Corrao, Alfonso Marchianò, Ugo Pastorino, Gabriella Sozzi
Publikováno v:
The Lancet Regional Health. Europe, Vol 46, Iss , Pp 101070- (2024)
Summary: Background: The proper management of suspicious radiologic findings is crucial to optimize the effectiveness of low-dose computed tomography (LDCT) lung cancer screening trials. In the BioMILD study, we evaluated the utility of combining a p
Externí odkaz:
https://doaj.org/article/5cc746aa733c4aacb5ce35387c21b4b6